SHAREHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger

NEW YORK, NY / ACCESSWIRE / May 5, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Stemline Therapeutics, Inc. (NASDAQ:STML) related to its sale to Berlin-Chemie AG. Under the terms of the agreement, Stemline shareholders will have the right to receive (i) $11.50 in cash plus (ii) one contingent value right for each share of Stemline common stock owned. Click here for more information: https://www.monteverdelaw.com/case/stemline-therapeutics-inc. It is free and there is no cost or obligation to you.
resTORbio, Inc. (NASDAQ:TORC) relating to the combination with Adicet Bio, Inc. Under the terms of the agreement, Adicet shareholders are expected to own approximately 75% of the combined company and resTORbio shareholders are expected to own 25%. Click here for more information: https://www.monteverdelaw.com/case/restorbio-inc. It is free and there is no cost or obligation to you.
Willis Towers Watson PLC (NASDAQ:WLTW) relating to its combination with Aon plc. Under the terms of the agreement, Willis Towers shareholders will be entitled to receive 1.08 newly issued Class A ordinary Aon share for each ordinary share of Willis Towers common stock owned. Click here for more information: https://www.monteverdelaw.com/case/willis-towers-watson-plc. It is free and there is no cost or obligation to you

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 alone, we recovered money for shareholders in 6 mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341 or cell (646) 522-4840.

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

CONTACT:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Cell: (646) 522-4840

SOURCE: Monteverde & Associates PC

ReleaseID: 588539

SHAREHOLDER ALERT: Monteverde & Associates PC is Investigating the Following Merger

NEW YORK, NY / ACCESSWIRE / January 22, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) related to its sale to Menlo Therapeutics, Inc. Under the terms of the transaction, Foamix shareholders will have the right to receive 0.5924 shares of Menlo common stock and one contingent stock right for each Foamix common stock owned. Click here for more information: https://www.monteverdelaw.com/case/foamix-pharmaceuticals-ltd. It is free and there is no cost or obligation to you.
Cincinnati Bell Inc. (NYSE:CBB) ("Cincinnati") relating to its sale to Charlie AcquireCo Inc. Under the terms of the sale, each share of Cincinnati common stock will be converted into the right to receive $10.50 in cash for each share of Cincinnati common stock owned. Click here for more information: https://www.monteverdelaw.com/case/cincinnati-bell-inc. It is free and there is no cost or obligation to you.
MutualFirst Financial, Inc (NASDAQ:MFSF) in regards to its sale to Northwest Bancshares, Inc. Under the terms of the Agreement, Shareholders of MutualFirst Financial have the right to receive 2.4 shares of Northwest Bancshares common stock. The total consideration of the transaction is approximately $346 Million. Click here for more information: https://www.monteverdelaw.com/case/mutualfirst-financial-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

SOURCE: Monteverde & Associates PC

ReleaseID: 573822

Go Top